本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

再鼎醫藥

41.00
-2.0300-4.72%
盤前40.52-0.4800-1.17%05:22 EDT
成交量:102.14萬
成交額:4,201.25萬
市值:44.47億
市盈率:-16.53
高:42.00
開:41.49
低:40.73
收:43.03
資料載入中...
2025/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/03

重要事件披露

Form 8-K - Current report
2024/12/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities